DrugPatentWatch Database Preview
LOTRIMIN ULTRA Drug Profile
When do Lotrimin Ultra patents expire, and what generic alternatives are available?
The generic ingredient in LOTRIMIN ULTRA is butenafine hydrochloride. There are two drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the butenafine hydrochloride profile page.
Summary for LOTRIMIN ULTRA
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 1 |
| Bulk Api Vendors: | 59 |
| Clinical Trials: | 3 |
| Patent Applications: | 249 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | see details |
| DailyMed Link: | LOTRIMIN ULTRA at DailyMed |
Synonyms for LOTRIMIN ULTRA
| (4-tert-butylphenyl)-N-methyl-N-(naphthalen-1-ylmethyl)methanaminium chloride |
| 1-(4-tert-butylphenyl)-N-methyl-N-(1-naphthalenylmethyl)methanamine hydrochloride |
| 1-(4-tert-butylphenyl)-N-methyl-N-(1-naphthylmethyl)methanamine hydrochloride |
| 1-(4-tert-butylphenyl)-N-methyl-N-(naphthalen-1-ylmethyl)methanamine hydrochloride |
| 101827-46-7 |
| 4-tert-butylbenzyl(methyl)(1-naphthalenemethyl)amine hydrochloride |
| 827B467 |
| A800463 |
| A800464 |
| AB0106850 |
| AB07686 |
| AC-2116 |
| AC1L9FCX |
| AKOS015895328 |
| AN-14303 |
| ANW-42439 |
| API0001792 |
| BC205781 |
| BCP9000464 |
| BG0596 |
| Butenafine (Hydrochloride) |
| Butenafine HCL |
| Butenafine hydrochloide |
| Butenafine hydrochloride |
| Butenafine hydrochloride (JP17/USAN) |
| Butenafine hydrochloride [USAN:JAN] |
| Butenafine hydrochloride, >=98% (HPLC) |
| BUTOP |
| C12490 |
| CAS-101827-46-7 |
| CC-25280 |
| CCG-220604 |
| CHEBI:31325 |
| CHEMBL1200397 |
| CS-1124 |
| CTK8B3383 |
| D01093 |
| DSSTox_CID_28515 |
| DSSTox_GSID_48589 |
| DSSTox_RID_82787 |
| DTXSID2048589 |
| FT-0631017 |
| FT-0699734 |
| HY-17396 |
| I06-0721 |
| J-000499 |
| K-0256 |
| KP-363 |
| KS-00000FUA |
| KS-1035 |
| LJBSAUIFGPSHCN-UHFFFAOYSA-N |
| Mentax |
| Mentax (TN) |
| MLS003899213 |
| MolPort-005-934-229 |
| N-((4-(1,1-Dimethylethyl)phenyl)methyl)-N-methyl-1-naphthalenemethanamine hydrochloride |
| N-(4-(tert-butyl)benzyl)-N-methyl-1-(naphthalen-1-yl)methanamine hydrochloride |
| N-(4-t-Butylbenzyl)-N-methyl-1-naphthalenemethylamine hydrochloride;N-(4-t-Butylbenzyl)-N-methyl-1-naphthalenemethylamine hydrochloride |
| N-(4-TERT-BUTYLBENZYL)-N-METHYL-1-NAPHTHALENEMETHYLAMINE HYDROCHLORIDE |
| N-(4-tert-butylbenzyl)-N-methyl-1-naphthylmethylamine hydrochloride |
| N-(p-tert-Butylbenzyl)-N-methyl-1-naphthalenemethylamine hydrochloride |
| N-[[4-(1,1-Dimethylethyl)phenyl]methyl]-N-methyl-1-naphthalenemethanamine hydrochloride |
| N-4-t-butylbenzyl-N-methyl-1-naphthalenemethylamine hydrochloride |
| N-4-tert-Butylbenzyl-N-methyl-1-naphthalenemethylamine hydrochloride |
| R8XA2029ZI |
| RTR-000443 |
| s3154 |
| SC-17334 |
| SCHEMBL262301 |
| Scorba |
| SMR002204106 |
| ST51052828 |
| SureCN1648813 |
| Tox21_112918 |
| TR-000443 |
| UNII-R8XA2029ZI |
| Volley |
| Volley (TN) |
US Patents and Regulatory Information for LOTRIMIN ULTRA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bayer Healthcare Llc | LOTRIMIN ULTRA | butenafine hydrochloride | CREAM;TOPICAL | 021307-001 | Dec 7, 2001 | OTC | Yes | Yes | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
